SOLENO THERAPEUTICS INC's ticker is SLNO and the CUSIP is 834203200. A total of 11 filers reported holding SOLENO THERAPEUTICS INC in Q4 2017. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $0 | – | 137 | 0.0% | 0.00% | – |
| Q1 2022 | $0 | – | 137 | -51.4% | 0.00% | – |
| Q4 2021 | $0 | – | 282 | 0.0% | 0.00% | – |
| Q3 2021 | $0 | -100.0% | 282 | -92.7% | 0.00% | – |
| Q2 2021 | $4,000 | -33.3% | 3,883 | -24.0% | 0.00% | – |
| Q1 2021 | $6,000 | -33.3% | 5,112 | +5.0% | 0.00% | – |
| Q4 2020 | $9,000 | – | 4,870 | +8443.9% | 0.00% | – |
| Q3 2020 | $0 | -100.0% | 57 | -89.3% | 0.00% | – |
| Q1 2020 | $1,000 | -50.0% | 535 | 0.0% | 0.00% | – |
| Q4 2019 | $2,000 | +100.0% | 535 | -5.8% | 0.00% | – |
| Q3 2019 | $1,000 | – | 568 | +3241.2% | 0.00% | – |
| Q2 2019 | $0 | – | 17 | -19.0% | 0.00% | – |
| Q1 2019 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | – | 21 | 0.0% | 0.00% | – |
| Q3 2018 | $0 | – | 21 | +2000.0% | 0.00% | – |
| Q2 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q1 2018 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 10,302,602 | $11,642,000 | 3.60% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,132,000 | $2,430,000 | 0.34% |
| Nantahala Capital Management | 9,765,129 | $11,132,000 | 0.32% |
| Tibra Equities Europe Ltd | 298,700 | $341,000 | 0.10% |
| OPPENHEIMER & CO INC | 633,571 | $722,000 | 0.01% |
| Ikarian Capital, LLC | 122,462 | $140,000 | 0.01% |
| XTX Topco Ltd | 24,975 | $28,000 | 0.01% |
| Ergoteles LLC | 270,700 | $309,000 | 0.01% |
| Warberg Asset Management LLC | 30,000 | $34,000 | 0.01% |
| Levy Wealth Management Group, LLC | 10,000 | $11,000 | 0.01% |